FDA Cyber Devices and SBOMs as Market Access Artifacts (W02a)
This talk uses FDA medical-device cybersecurity requirements as a practical model for SBOM as a regulatory artifact. It will explain how SBOMs fit into premarket submissions, vulnerability management, secure update processes, and post-market obligations—and what non-medical ICT vendors can learn from this more mature regulatory example.
